[HTML][HTML] Early initiation of extracorporeal blood purification using the AN69ST (oXiris®) hemofilter as a treatment modality for COVID-19 patients: a single-centre case …

P Ugurov, D Popevski, T Gramosli, D Neziri… - Brazilian Journal of …, 2021 - SciELO Brasil
Introduction: Severe coronavirus disease 2019 (COVID-19) is characterised by
hyperinflammatory state, systemic coagulopathies, and multiorgan involvement, especially …

Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris®) Hemofilter as a Treatment Modality for COVID-19 Patients: a Single-Centre Case …

P Ugurov, D Popevski, T Gramosli… - Brazilian Journal of …, 2022 - search.proquest.com
Introduction: Severe coronavirus disease 2019 (COVID-19) is characterised by
hyperinflammatory state, systemic coagulopathies, and multiorgan involvement, especially …

Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris®) Hemofilter as a Treatment Modality for COVID-19 Patients: a Single-Centre Case …

P Ugurov, D Popevski, T Gramosli… - Rev. bras. cir …, 2022 - pesquisa.bvsalud.org
Methods: Fifteen patients were included; several biomarkers associated with COVID-19
severity were monitored. Personalised treatment was tailored according to the levels of …

Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris®) Hemofilter as a Treatment Modality for COVID-19 Patients: a Single-Centre Case …

P Ugurov, D Popevski, T Gramosli… - Brazilian Journal of …, 2022 - search.ebscohost.com
Introduction: Severe coronavirus disease 2019 (COVID-19) is characterised by
hyperinflammatory state, systemic coagulopathies, and multiorgan involvement, especially …

[PDF][PDF] Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris®) Hemofilter as a Treatment Modality for COVID-19 Patients: a Single-Centre …

P Ugurov, D Popevski, T Gramosli, D Neziri… - Braz J Cardiovasc …, 2022 - scienceopen.com
Introduction: Severe coronavirus disease 2019 (COVID-19) is characterised by
hyperinflammatory state, systemic coagulopathies, and multiorgan involvement, especially …

[PDF][PDF] Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris®) Hemofilter as a Treatment Modality for COVID-19 Patients: a Single-Centre …

P Ugurov, D Popevski, T Gramosli, D Neziri… - Braz J Cardiovasc …, 2022 - bjcvs.org
Introduction: Severe coronavirus disease 2019 (COVID-19) is characterised by
hyperinflammatory state, systemic coagulopathies, and multiorgan involvement, especially …

[HTML][HTML] Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris®) Hemofilter as a Treatment Modality for COVID-19 Patients: a Single-Centre …

P Ugurov, D Popevski, T Gramosli, D Neziri… - Brazilian Journal of …, 2022 - ncbi.nlm.nih.gov
Methods Fifteen patients were included; several biomarkers associated with COVID-19
severity were monitored. Personalised treatment was tailored according to the levels of …

[PDF][PDF] Early initiation of Extracorporeal Blood Purification using the AN69ST (oXiris®) hemo filter as a treatment modality for COVID-19 patients: a single-centre case …

P Ugurov, D Popevski, T Gramosli, D Neziri, D Vuckova… - scholar.archive.org
Introduction: Our understanding of the COVID-19 disease has been steadily evolving since
the original outbreak in December 2019. Advanced disease is characterised by a hyperin …

[HTML][HTML] Early initiation of Extracorporeal Blood Purification using the AN69ST (oXiris®) hemofilter as a treatment modality for COVID-19 patients: a single-centre case …

P Ugurov, D Popevski, T Gramosli, D Neziri, D Vuckova… - 2020 - europepmc.org
Methods:: 15 patients were included; 2 were females. We monitored real-time several
biochemical, immunological and coagulation biomarkers associated with disease severity …

[HTML][HTML] Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris®) Hemofilter as a Treatment Modality for COVID-19 Patients: a Single-Centre …

P Ugurov, D Popevski, T Gramosli, D Neziri… - Brazilian Journal of …, 2021 - SciELO Brasil
Introduction: Severe coronavirus disease 2019 (COVID-19) is characterised by
hyperinflammatory state, systemic coagulopathies, and multiorgan involvement, especially …